Free Virtual Consultations. Corona Virus Related Cases Click Here.

Man Killed, 2 Injured in Crash on Ramona Expressway Near Hansen Avenue

Car Splits in Half in Fatal Nuevo Accident

Nuevo, CA (March 24, 2020) – A man was killed and two others were injured in a crash in Nuevo. The fatal accident occurred on the afternoon of March 24 on the Ramona Expressway.

A vehicle lost control on the Ramona Expressway, near Hansen Avenue. The speeding vehicle hit an object on the side of the road, possibly a pole. The car split in half.

One person died at the accident scene. Two others were hospitalized with moderate injuries.

 Our heartfelt condolences go out to the friends and loved ones of the victim.



October 17, 2019

Man Killed in Light Rail Train Crash Near Virginia Station

Victim Stuck Under Train in Fatal San Jose Accident San Jose, CA (October 15, 2...

January 23, 2020

David Callahan Killed in Crash at Dickinson and Herndon Avenues

Victim Launches Mercedes 330 Feet Across River in Fatal Fresno Accident...

October 31, 2019

1 Injured in Train Crash on 9th Street

Train, Car Collide in National City Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.